Ketoconazole as an adrenal steroidogenesis inhibitor: effectiveness and risks in the treatment of Cushing's disease
J Clin Endocrinol Metab
.
2014 May;99(5):1586-8.
doi: 10.1210/jc.2014-1622.
Author
John Newell-Price
1
Affiliation
1
Department of Human Metabolism, School of Medicine and Biomedical Science, University of Sheffield, Sheffield S10 2TN, United Kingdom.
PMID:
24802173
DOI:
10.1210/jc.2014-1622
No abstract available
Publication types
Editorial
Comment
MeSH terms
14-alpha Demethylase Inhibitors / therapeutic use*
Female
Humans
Ketoconazole / therapeutic use*
Male
Pituitary ACTH Hypersecretion / drug therapy*
Substances
14-alpha Demethylase Inhibitors
Ketoconazole